van Dam, M <br/><br/>
Long term efficacy and safety of atorvastatin in the treatment of severe type III and combined dyslipidaemia.  [electronic resource] 

 -  Heart (British Cardiac Society)  Sep 2002 
 - 234-8 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1468-201X 
<br/><br/><label>Standard No.: </label>10.1136/heart.88.3.234  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Apolipoproteins B--blood<br/>Atorvastatin<br/>Cholesterol--blood<br/>Female<br/>Heptanoic Acids--adverse effects<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--adverse effects<br/>Hyperlipidemias--blood<br/>Hyperlipoproteinemia Type III--blood<br/>Male<br/>Middle Aged<br/>Pyrroles--adverse effects<br/>Treatment Outcome<br/>Triglycerides--blood